CLBT – Cellebrite DI Ltd.
Float Short %
3.34
Margin Of Safety %
-30
Put/Call OI Ratio
0.19
EPS Next Q Diff
0.05
EPS Last/This Y
1.84
EPS This/Next Y
0.04
Price
16.12
Target Price
22.57
Analyst Recom
1
Performance Q
-3.59
Relative Volume
0.94
Beta
1.26
Ticker: CLBT
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-25 | CLBT | 14.31 | 0.21 | 0.04 | 7767 |
| 2025-07-28 | CLBT | 14.37 | 0.20 | 0.09 | 8122 |
| 2025-07-29 | CLBT | 14.49 | 0.20 | 0.02 | 8241 |
| 2025-07-30 | CLBT | 14.25 | 0.19 | 0.08 | 8324 |
| 2025-07-31 | CLBT | 13.98 | 0.19 | 0.08 | 8430 |
| 2025-08-01 | CLBT | 13.7 | 0.18 | 0.09 | 8788 |
| 2025-08-04 | CLBT | 13.6 | 0.17 | 0.01 | 9279 |
| 2025-08-05 | CLBT | 13.65 | 0.16 | 0.00 | 9859 |
| 2025-08-06 | CLBT | 13.86 | 0.16 | 0.01 | 10022 |
| 2025-08-07 | CLBT | 13.81 | 0.15 | 0.13 | 10156 |
| 2025-08-08 | CLBT | 13.57 | 0.15 | 0.03 | 10258 |
| 2025-08-11 | CLBT | 13.52 | 0.15 | 0.20 | 10574 |
| 2025-08-12 | CLBT | 13.89 | 0.15 | 0.01 | 11453 |
| 2025-08-13 | CLBT | 13.99 | 0.17 | 0.14 | 12918 |
| 2025-08-14 | CLBT | 15.3 | 0.17 | 0.19 | 14580 |
| 2025-08-15 | CLBT | 15.6 | 0.21 | 0.18 | 14893 |
| 2025-08-18 | CLBT | 16.17 | 0.19 | 0.17 | 13019 |
| 2025-08-19 | CLBT | 15.81 | 0.19 | 0.35 | 13152 |
| 2025-08-20 | CLBT | 15.48 | 0.19 | 0.10 | 13198 |
| 2025-08-21 | CLBT | 15.91 | 0.19 | 0.09 | 13301 |
| 2025-08-22 | CLBT | 16.12 | 0.19 | 0.18 | 13295 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-25 | CLBT | 14.32 | 7.0 | - | 0.46 |
| 2025-07-28 | CLBT | 14.34 | 7.0 | - | 0.46 |
| 2025-07-29 | CLBT | 14.49 | 7.0 | - | 0.46 |
| 2025-07-30 | CLBT | 14.25 | 7.0 | - | 0.46 |
| 2025-07-31 | CLBT | 13.98 | 7.0 | - | 0.46 |
| 2025-08-01 | CLBT | 13.70 | 7.0 | - | 0.46 |
| 2025-08-04 | CLBT | 13.64 | 7.0 | - | 0.46 |
| 2025-08-05 | CLBT | 13.65 | 7.0 | - | 0.46 |
| 2025-08-06 | CLBT | 13.87 | 7.0 | - | 0.46 |
| 2025-08-07 | CLBT | 13.82 | 7.0 | - | 0.46 |
| 2025-08-08 | CLBT | 13.57 | 7.0 | - | 0.46 |
| 2025-08-11 | CLBT | 13.52 | 7.0 | - | 0.46 |
| 2025-08-12 | CLBT | 13.89 | 7.0 | - | 0.46 |
| 2025-08-13 | CLBT | 13.99 | 7.0 | - | 0.46 |
| 2025-08-14 | CLBT | 15.30 | 7.0 | - | 0.46 |
| 2025-08-15 | CLBT | 15.60 | 7.0 | - | 0.49 |
| 2025-08-18 | CLBT | 16.18 | 28.9 | - | 0.49 |
| 2025-08-19 | CLBT | 15.80 | -7.8 | - | 0.49 |
| 2025-08-20 | CLBT | 15.49 | -7.8 | - | 0.49 |
| 2025-08-21 | CLBT | 15.90 | -7.8 | - | 0.49 |
| 2025-08-22 | CLBT | 16.12 | -7.8 | - | 0.49 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-25 | CLBT | 0.00 | -0.58 | 3.08 |
| 2025-07-28 | CLBT | 0.00 | -0.80 | 3.08 |
| 2025-07-29 | CLBT | 0.00 | -0.80 | 3.08 |
| 2025-07-30 | CLBT | 0.00 | -0.80 | 3.08 |
| 2025-07-31 | CLBT | 0.00 | -0.80 | 3.08 |
| 2025-08-01 | CLBT | 0.00 | -0.80 | 3.08 |
| 2025-08-04 | CLBT | 0.00 | -1.72 | 3.08 |
| 2025-08-05 | CLBT | 0.00 | -1.72 | 3.08 |
| 2025-08-06 | CLBT | 0.00 | -1.72 | 3.08 |
| 2025-08-07 | CLBT | 0.00 | -1.72 | 3.08 |
| 2025-08-08 | CLBT | 0.00 | -1.72 | 3.08 |
| 2025-08-11 | CLBT | 0.00 | 0.28 | 3.08 |
| 2025-08-12 | CLBT | 0.00 | 0.28 | 3.34 |
| 2025-08-13 | CLBT | 0.00 | 0.28 | 3.34 |
| 2025-08-14 | CLBT | 0.00 | 0.28 | 3.34 |
| 2025-08-15 | CLBT | 0.00 | 0.28 | 3.34 |
| 2025-08-18 | CLBT | 0.00 | -0.26 | 3.34 |
| 2025-08-19 | CLBT | 0.00 | -0.26 | 3.34 |
| 2025-08-20 | CLBT | 0.00 | -0.26 | 3.34 |
| 2025-08-21 | CLBT | 0.00 | -0.26 | 3.34 |
| 2025-08-22 | CLBT | 0.00 | -0.26 | 3.34 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.09
Avg. EPS Est. Current Quarter
0.13
Avg. EPS Est. Next Quarter
0.14
Insider Transactions
Institutional Transactions
-0.26
Beta
1.26
Average Sales Estimate Current Quarter
122
Average Sales Estimate Next Quarter
125
Fair Value
11.22
Quality Score
44
Growth Score
57
Sentiment Score
70
Actual DrawDown %
38.7
Max Drawdown 5-Year %
Target Price
22.57
P/E
Forward P/E
40.25
PEG
P/S
8.83
P/B
9.45
P/Free Cash Flow
25.7
EPS
-0.77
Average EPS Est. Cur. Y
0.49
EPS Next Y. (Est.)
0.52
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-34.56
Relative Volume
0.94
Return on Equity vs Sector %
-86.6
Return on Equity vs Industry %
-66.9
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
Cellebrite DI Ltd.Sector: Technology
Industry: Software - Infrastructure
Employees: 1167
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.
stock quote shares CLBT – Cellebrite DI Ltd. Stock Price stock today
news today CLBT – Cellebrite DI Ltd. stock forecast ,stock prediction 2023 2024 2025
marketwatch CLBT – Cellebrite DI Ltd. yahoo finance google finance
stock history CLBT – Cellebrite DI Ltd. invest stock market
stock prices CLBT premarket after hours
ticker CLBT fair value insiders trading